Keeping track of the world's biggest killers - Business - News - The Independent

Keeping track of the world's biggest killers

Magnus Grimond reports on an exiled professor who is pushing out the frontiers of medical science

If proof were needed that adversity is the crucible for creative genius, Salvador Moncada, the former head of research at drugs giant Wellcome, is surely it. Born of central European and Latin American parents, he knows better than most of us the pain of being forced out of your homeland.

His outlook has been forged by the experience of a family in permanent exile. His Jewish grandfather's forced emigration from Austria following Hitler's Anschluss in 1938 was followed 10 years later by his father having to flee his native Honduras after having fallen foul of the dictatorship which had come to power. By 1971, when Professor Moncada decided to quit Central America in disgust over the regime then terrorising his adopted El Salvador, he was following in a long family tradition.

But alongside this zeal to better the lot of his fellow man has burnt an equally strong desire to push out the frontiers of medical science. It is the triumph of that latter ambition which in the 1980s led Professor Moncada, while working at Wellcome, to the discovery of prostacyclin, a substance which stops blood clotting, and later to reveal the crucial importance of nitric oxide to the body's functioning. Former colleagues say that work brought him to within an ace of winning a Nobel prize. That same drive is now spurring him to establish the Cruciform Project, a ground- breaking attempt to set up a multi-disciplinary medical research facility bridging the gap between academia and industry.

For the past nine months, Professor Moncada and a team of 60 research scientists have set themselves up to unlock the secrets of some of the Western world's biggest killers. The research will concentrate on arteriosclerosis - heart attacks, strokes and the like; neuronal damage and repair - dealing with the after-effects of conditions such as stroke and Alzheimer's disease; and cancer.

But while millions of pounds are being thrown at similar research across the globe, the novelty of Professor Moncada's approach is the all-embracing nature of this new attack. Instead of being divided up into small teams, narrowly focused on specific disease areas, the Cruciform project will involve a large team of many disciplines working together using basic molecular science to achieve a common aim. The new institute, yet to be given a name, has attracted senior figures from both clinical science, such as Professor John Martin of the British Heart Foundation, and industry, including Professor Moncada's deputy, Ken Powell, formerly of Wellcome. Some 25 people from Wellcome's now-defunct research base at Beckenham in Kent have moved over to join Professor Moncada.

The significance of all this will not be lost on Britain's latest Nobel laureate, Sir Harold Croto, who warned this month that the low level of state funding meant research into basic science was "now below its survival threshold". The Government, he claimed, was using coercion to force scientists like him to work with industry.

The contrast with Professor Moncada's approach is stark. He has harnessed Government and industry in backing an institute dedicated to basic science. That has already won him pledges of support totalling pounds 26m from Government and the Wellcome Trust for the pounds 41.5m capital cost of converting the eponymous Cruciform building of the old University College Hospital in London. On top of that, the drugs industry and academic sources have promised pounds 2.5m of the expected pounds 12m to pounds 14m running costs when the institute opens in the autumn of 1998 with a staff of some 300.

Glaxo Wellcome, the drugs giant which last year subsumed Professor Moncada's former employer, is committing itself to pounds 10m over seven years to pursue research into the effect on septic shock of nitric oxide, the area which Professor Moncada pioneered as head of Wellcome's research efforts in the 1980s. Glaxo Wellcome will keep the intellectual property rights, with the Moncada institute receiving royalties from any new drugs which result from the work.

Outsiders suggest there is the prospect for a whole series of similar deals. Rolf Stahel, another member of the Wellcome diaspora, who is now chief executive of biotech group Shire Pharmaceuticals, says his group and Professor Moncada's are "beautifully complementary".

Shire will be looking hard at fundamental work carried out at the institute in areas such as the central nervous system for potential development prospects. But there will be no millionaire boffins a la British Biotech from new blockbuster cures based on work coming from UCL. The majority of the royalties will be ploughed back into what Professor Moncada emphasises will be basic science. "We are going to do fundamental research as the main point of our activity. I think what we are doing is exploiting the interface between academia and industry," he says.

In the first instance, this will be to apply discoveries in a more efficient way and secondly to fund further fundamental research. "One of the problems [of this country] has been the slow transfer of scientific knowledge into practical applications. That is one of the gaps we want to bridge," he says.

Professor Moncada sees a growing need for a basic research body of this sort, given the trend towards consolidation in the drugs industry. "I think the pressures from the market are forcing the industry to concentrate on development rather than research. My feeling is the drugs industry will rely more and more on academic research and smaller, start-up companies. They will be more efficient and more productive."

But he differentiates Cruciform from biotechnology companies such as British Biotech and Shire. The emphasis of the science used by such companies is on large-scale molecular biology, he says, using proteins and peptides. By contrast, his institute will use smaller molecules and concentrate on how they affect chemical processes, rather than creating drugs or cures for diseases.

It is a noble enterprise, at least as worthy as his attempts to aid his fellow countrymen in Central America, and one that would present a challenge to a young person, let alone a man of 51. But Professor Moncada is used to radical departures, having had literal experience of them in his flights from various dictatorships.

On past form, he will scale this new peak with ease, potentially giving London a new centre of excellence in medicine, not just in research, but in teaching too. The institute should be up and running in time for the planned merger of London's Royal Free, Middlesex and University College medical schools. After that, who knows.

"I have never made long-term plans, although I have done things for a long time," he says. "I have been a scientist for a quarter of a century. I would like to believe that I still will have the flexibility to look for the excitement and go for it, rather than settling."

John Travolta is a qualified airline captain and employed the pilot with his company, Alto
people'That was the lowest I’d ever felt'
Life and Style
healthIt isn’t greasy. It doesn’t smell. And moreover, it costs nothing
peopleThe report and photo dedicated to the actress’s decolletage has, unsurprisingly, provoked anger
Home body: Badger stays safe indoors
The programme sees four specialists creating what they believe are three perfect couples, based on scientific matchmaking. The couples will not meet until they walk down the aisle together
tvUK wedding show jilted
Arts and Entertainment
US pop diva Jennifer Lopez sang “Happy Birthday” to Gurbanguly Berdimuhamedow, president of Turkmenistan
musicCorporate gigs become key source of musicians' income
Arts and Entertainment
You've been framed: Henri Matisse's colourful cut-outs at Tate Modern
artWhat makes a smash-hit art show
ebooksAn unforgettable anthology of contemporary reportage
Arts and Entertainment
While many films were released, few managed to match the success of James Bond blockbuster 'Skyfall'
filmsDaniel Craig believed to be donning skis as 007 for first time
Mikel Arteta pictured during Borussia Dortmund vs Arsenal
champions league
Yes supporters gather outside the Usher Hall, which is hosting a Night for Scotland in Edinburgh
voicesBen Judah: Is there a third option for England and Scotland that keeps everyone happy?
Arts and Entertainment
Pulp-fiction lover: Jarvis Cocker
booksJarvis Cocker on Richard Brautigan
Arts and Entertainment
Robin Thicke and Pharell Williams in the video of the song, which has been accused of justifying rape
music...and he had 'almost no part' in writing it
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Sales Executive

£20 - 24k (Uncapped Commission - £35k Year 1 OTE): Guru Careers: We are seekin...

Payroll & Accounts Assistant

£20 - 24k + Benefits: Guru Careers: This is a great opportunity for an enthusi...

SQL Developer - Watford/NW London - £280 - £320 p/d - 6 months

£280 - £320 per day: Ashdown Group: The Ashdown Group have been engaged by a l...

Senior BA - Insurance **URGENT**

£400 - £450 Per Day: Clearwater People Solutions Ltd: **URGENT CONTRACT ROLE**...

Day In a Page

Mystery of the Ground Zero wedding photo

A shot in the dark

Mystery of the wedding photo from Ground Zero
His life, the universe and everything

His life, the universe and everything

New biography sheds light on comic genius of Douglas Adams
Save us from small screen superheroes

Save us from small screen superheroes

Shows like Agents of S.H.I.E.L.D are little more than marketing tools
Reach for the skies

Reach for the skies

From pools to football pitches, rooftop living is looking up
These are the 12 best hotel spas in the UK

12 best hotel spas in the UK

Some hotels go all out on facilities; others stand out for the sheer quality of treatments
These Iranian-controlled Shia militias used to specialise in killing American soldiers. Now they are fighting Isis, backed up by US airstrikes

Widespread fear of Isis is producing strange bedfellows

Iranian-controlled Shia militias that used to kill American soldiers are now fighting Isis, helped by US airstrikes
Topshop goes part Athena poster, part last spring Prada

Topshop goes part Athena poster, part last spring Prada

Shoppers don't come to Topshop for the unique
How to make a Lego masterpiece

How to make a Lego masterpiece

Toy breaks out of the nursery and heads for the gallery
Meet the ‘Endies’ – city dwellers who are too poor to have fun

Meet the ‘Endies’ – city dwellers who are too poor to have fun

Urbanites are cursed with an acronym pointing to Employed but No Disposable Income or Savings
Paisley’s decision to make peace with IRA enemies might remind the Arabs of Sadat

Ian Paisley’s decision to make peace with his IRA enemies

His Save Ulster from Sodomy campaign would surely have been supported by many a Sunni imam
'She was a singer, a superstar, an addict, but to me, her mother, she is simply Amy'

'She was a singer, a superstar, an addict, but to me, her mother, she is simply Amy'

Exclusive extract from Janis Winehouse's poignant new memoir
Is this the role to win Cumberbatch an Oscar?

Is this the role to win Cumberbatch an Oscar?

The Imitation Game, film review
England and Roy Hodgson take a joint step towards redemption in Basel

England and Hodgson take a joint step towards redemption

Welbeck double puts England on the road to Euro 2016
Relatives fight over Vivian Maier’s rare photos

Relatives fight over Vivian Maier’s rare photos

Pictures removed from public view as courts decide ownership
‘Fashion has to be fun. It’s a big business, not a cure for cancer’

‘Fashion has to be fun. It’s a big business, not a cure for cancer’

Donatella Versace at New York Fashion Week